Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06025916

Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial (PROTECT)

Postpartum Hemorrhage Reduction With Oral Tranexamic Acid (PROTECT): a Multicenter Randomized Controlled Trial

Sponsor: Karolinska Institutet

Conditions PPH

Updated 5 times since 2023 Last updated: Sep 17, 2024 Started: Sep 27, 2023 Primary completion: Dec 31, 2025 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06025916, this PHASE4 trial focuses on PPH and remains actively recruiting participants. Sponsored by Karolinska Institutet, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Oct 2024 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Nov 2023 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Oct 2023 — Nov 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet
Stockholm South General Hospital
University of Cape Town

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden